Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer

Growing experience with engineered chimeric antigen receptor (CAR)‐T cells has revealed some of the challenges associated with developing patient‐specific therapy. The promising clinical results obtained with CAR‐T therapy nevertheless demonstrate the urgency of advancements to promote and expand it...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalla, Ahmed M. E., Xiao, Lin, Miao, Yu, Huang, Lixia, Fadlallah, Gendeal M., Gauthier, Mario, Ouyang, Chenxi, Yang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Progress Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237845/
https://www.ncbi.nlm.nih.gov/pubmed/32440473
http://dx.doi.org/10.1002/advs.201903164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237845/
https://www.ncbi.nlm.nih.gov/pubmed/32440473
http://dx.doi.org/10.1002/advs.201903164

Ejemplares similares